These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 1982072

  • 21. Modulation of the catalytic activity of the Src family tyrosine kinase Hck by autophosphorylation at a novel site in the unique domain.
    Johnson TM, Williamson NA, Scholz G, Jaworowski A, Wettenhall RE, Dunn AR, Cheng HC.
    J Biol Chem; 2000 Oct 27; 275(43):33353-64. PubMed ID: 10934191
    [Abstract] [Full Text] [Related]

  • 22. Substitution of the erbB-2 oncoprotein transmembrane domain activates the insulin receptor and modulates the action of insulin and insulin-receptor substrate 1.
    Cheatham B, Shoelson SE, Yamada K, Goncalves E, Kahn CR.
    Proc Natl Acad Sci U S A; 1993 Aug 01; 90(15):7336-40. PubMed ID: 7688476
    [Abstract] [Full Text] [Related]

  • 23. pp60c-src variants containing lesions that affect phosphorylation at tyrosines 416 and 527.
    Harvey R, Hehir KM, Smith AE, Cheng SH.
    Mol Cell Biol; 1989 Sep 01; 9(9):3647-56. PubMed ID: 2476663
    [Abstract] [Full Text] [Related]

  • 24. Identification of RET autophosphorylation sites by mass spectrometry.
    Kawamoto Y, Takeda K, Okuno Y, Yamakawa Y, Ito Y, Taguchi R, Kato M, Suzuki H, Takahashi M, Nakashima I.
    J Biol Chem; 2004 Apr 02; 279(14):14213-24. PubMed ID: 14711813
    [Abstract] [Full Text] [Related]

  • 25. Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation.
    Kmiecik TE, Shalloway D.
    Cell; 1987 Apr 10; 49(1):65-73. PubMed ID: 3103925
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Distinct tyrosine autophosphorylation sites negatively and positively modulate neu-mediated transformation.
    Dankort DL, Wang Z, Blackmore V, Moran MF, Muller WJ.
    Mol Cell Biol; 1997 Sep 10; 17(9):5410-25. PubMed ID: 9271418
    [Abstract] [Full Text] [Related]

  • 29. Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene.
    Bargmann CI, Weinberg RA.
    Proc Natl Acad Sci U S A; 1988 Aug 10; 85(15):5394-8. PubMed ID: 2899890
    [Abstract] [Full Text] [Related]

  • 30. Tissue-specific transformation by epidermal growth factor receptor: a single point mutation within the ATP-binding pocket of the erbB product increases its intrinsic kinase activity and activates its sarcomagenic potential.
    Shu HK, Pelley RJ, Kung HJ.
    Proc Natl Acad Sci U S A; 1990 Dec 10; 87(23):9103-7. PubMed ID: 1979168
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Regulation by the autophosphorylation site in overexpressed pp60c-src.
    Kmiecik TE, Johnson PJ, Shalloway D.
    Mol Cell Biol; 1988 Oct 10; 8(10):4541-6. PubMed ID: 2460746
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Identification of tyrosine 706 in the kinase insert as the major colony-stimulating factor 1 (CSF-1)-stimulated autophosphorylation site in the CSF-1 receptor in a murine macrophage cell line.
    van der Geer P, Hunter T.
    Mol Cell Biol; 1990 Jun 10; 10(6):2991-3002. PubMed ID: 2160591
    [Abstract] [Full Text] [Related]

  • 37. A major site of tyrosine phosphorylation within the SH2 domain of Fujinami sarcoma virus P130gag-fps is not required for protein-tyrosine kinase activity or transforming potential.
    Weinmaster GA, Middlemas DS, Hunter T.
    J Virol; 1988 Jun 10; 62(6):2016-25. PubMed ID: 2452898
    [Abstract] [Full Text] [Related]

  • 38. Modulation of erbB kinase activity and oncogenic potential by single point mutations in the glycine loop of the catalytic domain.
    Shu HK, Chang CM, Ravi L, Ling L, Castellano CM, Walter E, Pelley RJ, Kung HJ.
    Mol Cell Biol; 1994 Oct 10; 14(10):6868-78. PubMed ID: 7935404
    [Abstract] [Full Text] [Related]

  • 39. Protein tyrosine kinase activities of the epidermal growth factor receptor and ErbB proteins: correlation of oncogenic activation with altered kinetics.
    Nair N, Davis RJ, Robinson HL.
    Mol Cell Biol; 1992 May 10; 12(5):2010-6. PubMed ID: 1314948
    [Abstract] [Full Text] [Related]

  • 40. Activation of p56lck through mutation of a regulatory carboxy-terminal tyrosine residue requires intact sites of autophosphorylation and myristylation.
    Abraham N, Veillette A.
    Mol Cell Biol; 1990 Oct 10; 10(10):5197-206. PubMed ID: 1697929
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.